Additionally, serotonin antagonism may dysregulate dopaminergic control of micturition-5-HT2A inhibition increases dopamine D1 activity, suppressing overactive bladder, while D2 activation may paradoxically worsen detrusor overactivity [16,17]. The gene discussed is HTR2A; the disease is overactive bladder.